- Clinical Trials
- November 2024
- 180 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- October 2024
- 237 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Clinical Trials
- June 2024
- 80 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- September 2024
- 184 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- July 2024
- 110 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- October 2024
- 149 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- May 2024
- 160 Pages
Global
From €4742EUR$4,969USD£3,973GBP
- Report
- October 2023
- 157 Pages
Global
From €4438EUR$4,650USD£3,718GBP
- Report
- August 2019
- 30 Pages
China
From €2100EUR$2,200USD£1,759GBP
- Report
- August 2022
- 117 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- April 2023
- 224 Pages
Global
From €7158EUR$7,500USD£5,997GBP
- Report
- April 2023
- 112 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- December 2022
- 115 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- May 2023
- 160 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- August 2022
- 110 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Drug Pipelines
- October 2020
- 773 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Drug Pipelines
- September 2020
- 35 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Drug Pipelines
- January 2019
- 163 Pages
Global
From €20996EUR$22,000USD£17,592GBP
- Report
- July 2018
- 14 Pages
Global
From €9544EUR$10,000USD£7,996GBP
- Report
- August 2022
- 580 Pages
Global
From €2386EUR$2,500USD£1,999GBP

Thrombolytics are a class of cardiovascular drugs used to treat acute ischemic stroke, myocardial infarction, and pulmonary embolism. They work by breaking down the clot that is blocking the blood vessel, allowing blood to flow freely. Thrombolytics are typically administered intravenously, and can be used in combination with other treatments such as anticoagulants and antiplatelet drugs. The most commonly used thrombolytic is tissue plasminogen activator (tPA), which is a recombinant form of the naturally occurring enzyme plasminogen.
The thrombolytics market is highly competitive, with a number of companies offering products for the treatment of cardiovascular diseases. Some of the major players in the market include Boehringer Ingelheim, Pfizer, Sanofi, Bristol-Myers Squibb, and Merck. Show Less Read more